{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:42:09Z","timestamp":1792194129879,"version":"4.4.0"},"reference-count":166,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.jep.2006.02.001","type":"journal-article","created":{"date-parts":[[2006,3,16]],"date-time":"2006-03-16T12:17:02Z","timestamp":1142511422000},"page":"1-25","source":"Crossref","is-referenced-by-count":406,"title":["Cannabinoids in medicine: A review of their therapeutic potential"],"prefix":"10.1016","volume":"105","author":[{"given":"Mohamed","family":"Ben Amar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2006.02.001_bib1","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/0003-4819-139-4-200308190-00008","article-title":"Short-term effects of cannabinoids in patients with HIV-1 infection. A randomized, placebo-controlled clinical trial","volume":"139","author":"Abrams","year":"2003","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jep.2006.02.001_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/bjc.1983.247","article-title":"Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy","volume":"48","author":"Ahmedzai","year":"1983","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.jep.2006.02.001_bib3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.pbb.2005.02.015","article-title":"The role of endocannabinoid transmission in cocaine addiction","volume":"81","author":"Arnold","year":"2005","journal-title":"Pharmacology, Biochemistry and Behavior"},{"key":"10.1016\/j.jep.2006.02.001_bib4","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/bmj.325.7374.1212","article-title":"Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study","volume":"325","author":"Arseneault","year":"2002","journal-title":"British Medical Journal"},{"key":"10.1016\/j.jep.2006.02.001_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1192\/bjp.178.2.101","article-title":"Pharmacology and effects of cannabis: a brief review","volume":"178","author":"Ashton","year":"2001","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jep.2006.02.001_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/082585970201800207","article-title":"Medical efficacy of cannabinoids and marijuana: a comprehensive review of the literature","volume":"18","author":"Bagshaw","year":"2002","journal-title":"Journal of Palliative Care"},{"key":"10.1016\/j.jep.2006.02.001_bib7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1474-4422(03)00381-8","article-title":"The therapeutic potential of cannabis","volume":"2","author":"Baker","year":"2003","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.jep.2006.02.001_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0885-3924(94)00117-4","article-title":"Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS","volume":"10","author":"Beal","year":"1995","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1016\/j.jep.2006.02.001_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7400","article-title":"Treatments for spasticity and pain in multiple sclerosis: a systematic review","volume":"7","author":"Beard","year":"2003","journal-title":"Health Technology Assessment"},{"key":"10.1016\/j.jep.2006.02.001_bib10","series-title":"Cannabis","first-page":"99","article-title":"La recherche m\u00e9dicale sur le cannabis dans le traitement de la douleur au Canada: pass\u00e9, pr\u00e9sent et futur?","author":"Beaulieu","year":"2004"},{"key":"10.1016\/j.jep.2006.02.001_bib11","series-title":"Cannabis","first-page":"9","article-title":"Pharmacologie du cannabis et synth\u00e8se des analyses des principaux comit\u00e9s d\u2019experts","author":"Ben Amar","year":"2004"},{"key":"10.1016\/j.jep.2006.02.001_bib12","series-title":"Les Psychotropes: Pharmacologie et Toxicomanie","first-page":"571","article-title":"Chapter 16: Cannabis","author":"Ben Amar","year":"2002"},{"key":"10.1016\/j.jep.2006.02.001_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.pain.2004.09.013","article-title":"Efficacy of two cannabis based medicinal extracts for relief on central neuropathic pain from brachial plexus avulsion: results of a randomized controlled trial","volume":"112","author":"Berman","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.jep.2006.02.001_bib14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nm0602-547","article-title":"Targeting the endocannabinoid system in cancer therapy: a call for further research","volume":"8","author":"Bifulco","year":"2002","journal-title":"Nature Medicine"},{"key":"10.1016\/j.jep.2006.02.001_bib15","doi-asserted-by":"crossref","unstructured":"Blake, D.R., Robson, P., Ho, M., Jubb, R.W., McCabe, C.S., 2005. Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology (advance access published November 9, 2005).","DOI":"10.1093\/rheumatology\/kei183"},{"key":"10.1016\/j.jep.2006.02.001_bib16","series-title":"Therapeutic Uses of Cannabis","author":"British Medical Association","year":"1997"},{"key":"10.1016\/j.jep.2006.02.001_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3959(03)00331-2","article-title":"Lack of analgesic efficacy of oral \u2202-9-tetrahydrocannabinol in postoperative pain","volume":"106","author":"Buggy","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.jep.2006.02.001_bib18","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.lfs.2004.04.010","article-title":"Ajulemic acid: a novel cannabinoid produces analgesia without a \u201chigh\u201d","volume":"75","author":"Burstein","year":"2004","journal-title":"Life Sciences"},{"key":"10.1016\/j.jep.2006.02.001_bib19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0165-5728(97)00227-0","article-title":"Drugs and immunity: cannabinoids and their role in decreased resistance to infectious diseases","volume":"83","author":"Cabral","year":"1998","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.jep.2006.02.001_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.323.7303.13","article-title":"Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review","volume":"323","author":"Campbell","year":"2001","journal-title":"British Medical Journal"},{"key":"10.1016\/j.jep.2006.02.001_bib21","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1212\/01.WNL.0000140288.48796.8E","article-title":"Cannabis for dyskinesia in Parkinson disease. A randomized double-blind crossover study","volume":"63","author":"Carroll","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jep.2006.02.001_bib22","first-page":"464","article-title":"Medicinal cannabis: rational guidelines for dosing","volume":"75","author":"Carter","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.jep.2006.02.001_bib23","first-page":"946","article-title":"Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind crossover trial","volume":"79","author":"Chan","year":"1987","journal-title":"Pediatrics"},{"key":"10.1016\/j.jep.2006.02.001_bib24","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/1097-0142(19810401)47:7<1746::AID-CNCR2820470704>3.0.CO;2-4","article-title":"A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy","volume":"47","author":"Chang","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.jep.2006.02.001_bib25","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/0003-4819-91-6-819","article-title":"Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate","volume":"91","author":"Chang","year":"1979","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jep.2006.02.001_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2307\/3343473","article-title":"The ethics of medical marijuana: government restrictions vs medical necessity","volume":"21","author":"Clark","year":"2000","journal-title":"Journal of Public Health Policy"},{"key":"10.1016\/j.jep.2006.02.001_bib27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ana.410130616","article-title":"Tetrahydrocannabinol for tremor in multiple sclerosis","volume":"13","author":"Clifford","year":"1983","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.jep.2006.02.001_bib28","first-page":"449","article-title":"The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy","volume":"91","author":"Colls","year":"1980","journal-title":"New Zealand Medical Journal"},{"key":"10.1016\/j.jep.2006.02.001_bib29","series-title":"Marihuana and Medicine","first-page":"611","article-title":"Clinical and experimental reports of marihuana and cannabinoids in spastic disorders","author":"Consroe","year":"1999"},{"key":"10.1016\/j.jep.2006.02.001_bib30","series-title":"Marijuana\/Cannabinoids: Neurobiology and Neurophysiology","first-page":"459","article-title":"Potential role of cannabinoids for therapy of neurological disorders","author":"Consroe","year":"1992"},{"key":"10.1016\/j.jep.2006.02.001_bib31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.234.3.306","article-title":"Anticonvulsant nature of marihuana smoking","volume":"234","author":"Consroe","year":"1975","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jep.2006.02.001_bib32","series-title":"Compendium of Pharmaceuticals and Specialties","author":"CPA","year":"2005"},{"key":"10.1016\/j.jep.2006.02.001_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF02934575","article-title":"Nabilone and metoclopramide in the treatment of nausea and vomiting due to cisplatinum: a double-blind study","volume":"3","author":"Crawford","year":"1986","journal-title":"Medical Oncology and Tumor Pharmacotherapy"},{"key":"10.1016\/j.jep.2006.02.001_bib34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1358\/dot.2004.40.8.850469","article-title":"Towards cannabis and cannabinoid treatment of multiple sclerosis","volume":"40","author":"Croxford","year":"2004","journal-title":"Drugs Today"},{"key":"10.1016\/j.jep.2006.02.001_bib35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000137430","article-title":"Chronic administration of cannabidiol to healthy volunteers and epileptic patients","volume":"21","author":"Cunha","year":"1980","journal-title":"Pharmacology"},{"key":"10.1016\/j.jep.2006.02.001_bib36","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/adc.61.5.502","article-title":"Nabilone: an alternative antiemetic for cancer chemotherapy","volume":"61","author":"Dalzell","year":"1986","journal-title":"Archives of Disease in Childhood"},{"key":"10.1016\/j.jep.2006.02.001_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0376-8716(03)00064-4","article-title":"Testing hypotheses about the relationship between cannabis use and psychosis","volume":"71","author":"Degenhardt","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jep.2006.02.001_bib38","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1200\/JCO.2005.04.150","article-title":"Medicinal cannabis in oncology practice: still a bridge too far?","volume":"23","author":"de Jong","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.jep.2006.02.001_bib39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0035-3787(04)71013-9","article-title":"Cannabis et r\u00e9cepteurs cannabino\u00efdes: de la physiopathologie aux possibilit\u00e9s th\u00e9rapeutiques","volume":"160","author":"Derkinderen","year":"2004","journal-title":"Revue de Neurologie"},{"key":"10.1016\/j.jep.2006.02.001_bib40","first-page":"605","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.jep.2006.02.001_bib41","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nm1001-1151","article-title":"A cannabinoid mechanism in relapse to cocaine seeking","volume":"7","author":"De Vries","year":"2001","journal-title":"Nature Medicine"},{"key":"10.1016\/j.jep.2006.02.001_bib42","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd1495","article-title":"The endocannabinoid system and its therapeutic exploitation","volume":"3","author":"Di Marzo","year":"2004","journal-title":"Nature Reviews"},{"key":"10.1016\/j.jep.2006.02.001_bib43","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1157\/13059327","article-title":"Novedades sobre las potencialidades terap\u00e9uticas del cannabis y el sistema cannabinoide","volume":"122","author":"Duran","year":"2004","journal-title":"Medicina Clinica"},{"key":"10.1016\/j.jep.2006.02.001_bib44","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.1002\/j.1552-4604.1981.tb02576.x","article-title":"Nabilone: an effective antiemetic in patients receiving cancer chemotherapy","volume":"21","author":"Einhorn","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jep.2006.02.001_bib45","first-page":"439","article-title":"Complex partial seizure symptoms affected by marijuana abuse","volume":"51","author":"Ellison","year":"1990","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jep.2006.02.001_bib46","series-title":"Cannabis and Cannabinoids: Pharmacology, Toxicology and Therapeutic Potential","first-page":"37","article-title":"Chapter 4: history of cannabis in Western medicine","author":"Fankhauser","year":"2002"},{"key":"10.1016\/j.jep.2006.02.001_bib47","first-page":"115","article-title":"Le cannabis: ses effets sur la sant\u00e9","volume":"1","author":"Fehr","year":"1983","journal-title":"Psychotropes"},{"key":"10.1016\/j.jep.2006.02.001_bib48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1017\/S0033291702006402","article-title":"Cannabis dependence and psychotic symptoms in young people","volume":"33","author":"Fergusson","year":"2003","journal-title":"Psychological medicine"},{"key":"10.1016\/j.jep.2006.02.001_bib49","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1212\/01.WNL.0000118203.67138.3E","article-title":"The effect of cannabis on tremor in patients with multiple sclerosis","volume":"62","author":"Fox","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jep.2006.02.001_bib50","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/mds.1280","article-title":"Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia","volume":"17","author":"Fox","year":"2002","journal-title":"Movement Disorders"},{"key":"10.1016\/j.jep.2006.02.001_bib51","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-91-6-825","article-title":"Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy","volume":"91","author":"Frytak","year":"1979","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jep.2006.02.001_bib52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/108729104323038892","article-title":"Medicinal and recreational marijuana use by patients infected with HIV","volume":"18","author":"Furler","year":"2004","journal-title":"Aids Patient Care and STDs"},{"key":"10.1016\/j.jep.2006.02.001_bib53","first-page":"24","article-title":"Essai comparatif randomis\u00e9 d\u2019un nouvel anti-\u00e9m\u00e9tique: la nabilone, chez des malades canc\u00e9reuses trait\u00e9es par le cis-platinum","volume":"37","author":"George","year":"1983","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.jep.2006.02.001_bib54","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1212\/01.WNL.0000152845.09088.28","article-title":"Medical use of cannabis in the Netherlands","volume":"64","author":"Gorter","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jep.2006.02.001_bib55","first-page":"163","article-title":"Antiemetic therapy: a review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol","volume":"68","author":"Gralla","year":"1984","journal-title":"Cancer Treatment Reports"},{"key":"10.1016\/j.jep.2006.02.001_bib56","series-title":"Glaucoma: Applied Pharmacology in Medical Treatment","first-page":"507","article-title":"Chapter 21: marijuana effects on intraocular pressure","author":"Green","year":"1984"},{"key":"10.1016\/j.jep.2006.02.001_bib57","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/clpt.1994.33","article-title":"Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers","volume":"55","author":"Greenberg","year":"1994","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.jep.2006.02.001_bib58","series-title":"Marihuana. The Forbidden Medicine","author":"Grinspoon","year":"1997"},{"key":"10.1016\/j.jep.2006.02.001_bib59","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/02791072.1998.10399683","article-title":"Medicinal marijuana: a comprehensive review","volume":"30","author":"Gurley","year":"1998","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.jep.2006.02.001_bib60","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0140-6736(98)05021-1","article-title":"Adverse effects of cannabis","volume":"352","author":"Hall","year":"1998","journal-title":"The Lancet"},{"key":"10.1016\/j.jep.2006.02.001_bib61","first-page":"198","article-title":"The effect of \u03949-THC on human spasticity","volume":"39","author":"Hanigan","year":"1986","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.jep.2006.02.001_bib62","series-title":"The Health Effects of Cannabis","first-page":"461","article-title":"Therapeutic uses of cannabis and cannabinoids","author":"Hartel","year":"1999"},{"key":"10.1016\/j.jep.2006.02.001_bib63","series-title":"Medical Marihuana Research Program","author":"Health Canada\/CIHR","year":"1999"},{"key":"10.1016\/j.jep.2006.02.001_bib64","series-title":"Medical Use of Marihuana. Stakeholder Statistics","author":"Health Canada","year":"2005"},{"key":"10.1016\/j.jep.2006.02.001_bib65","series-title":"The Pharmacology of Marihuana","first-page":"815","article-title":"Ocular effects of marihuana smoking","author":"Hepler","year":"1976"},{"key":"10.1016\/j.jep.2006.02.001_bib66","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJM197906073002302","article-title":"Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy","volume":"300","author":"Herman","year":"1979","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jep.2006.02.001_bib67","first-page":"1397","article-title":"Editorial. Marijuana: federal smoke clears a little","volume":"164","author":"Hoey","year":"2001","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.jep.2006.02.001_bib68","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2044.1997.139-az0132.x","article-title":"Pain relief with oral cannabinoids in familial Mediterranean fever","volume":"52","author":"Holdcroft","year":"1997","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jep.2006.02.001_bib69","series-title":"Cannabis: The Scientific and Medical Evidence","author":"House of Lords, Select Committee on Science and Technology","year":"1998"},{"key":"10.1016\/j.jep.2006.02.001_bib70","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/0277-5379(83)90032-9","article-title":"A randomised multicentre single blind comparison of a cannabinoid anti-emetic (levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapy","volume":"19","author":"Hutcheon","year":"1983","journal-title":"European Journal of Cancer and Clinical Oncology"},{"key":"10.1016\/j.jep.2006.02.001_bib71","series-title":"Division of Neuroscience and Behavioral Health","article-title":"Marijuana and medicine. Assessing the science base","author":"Institute of Medicine","year":"1999"},{"key":"10.1016\/j.jep.2006.02.001_bib72","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/brain\/awg143","article-title":"Cannabis and the brain","volume":"126","author":"Iversen","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jep.2006.02.001_bib73","series-title":"The Science of Marijuana","first-page":"121","article-title":"Chapter 4: medical uses of marijuana. Fact or fantasy?","author":"Iversen","year":"2000"},{"key":"10.1016\/j.jep.2006.02.001_bib74","doi-asserted-by":"crossref","first-page":"320S","DOI":"10.1002\/j.1552-4604.1981.tb02610.x","article-title":"Evaluation of intramuscular levonantradol and placebo in acute postoperative pain","volume":"21","author":"Jain","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jep.2006.02.001_bib75","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0163-7258(02)00259-0","article-title":"Cannabinoids in the treatment of glaucoma","volume":"95","author":"J\u00e4rvinen","year":"2002","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.jep.2006.02.001_bib76","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1200\/JCO.20.2.567","article-title":"Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North central cancer treatment group study","volume":"20","author":"Jatoi","year":"2002","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.jep.2006.02.001_bib77","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/cpt1978242223","article-title":"Effect of benzopyranoperidine a \u0394-9-THC congener, on pain","volume":"24","author":"Jochimsen","year":"1978","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.jep.2006.02.001_bib78","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0305-7372(82)80032-7","article-title":"A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy","volume":"9","author":"Johansson","year":"1982","journal-title":"Cancer Treatment Reviews"},{"key":"10.1016\/j.jep.2006.02.001_bib79","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0305-7372(82)80035-2","article-title":"A multi-institutional phase III study of nabilone vs placebo in chemotherapy-induced nausea and vomiting","volume":"9","author":"Jones","year":"1982","journal-title":"Cancer Treatment Reviews"},{"key":"10.1016\/j.jep.2006.02.001_bib80","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejca.2004.09.026","article-title":"Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment","volume":"41","author":"Jordan","year":"2005","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.jep.2006.02.001_bib81","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1001\/jama.290.13.1757","article-title":"Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain. A randomized controlled trial","volume":"290","author":"Karst","year":"2003","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jep.2006.02.001_bib82","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1001\/jama.261.23.3424","article-title":"No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals","volume":"261","author":"Kaslow","year":"1989","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jep.2006.02.001_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-200464010-00001","article-title":"Cannabinoids in multiple sclerosis. Do they have a therapeutic role?","volume":"64","author":"Killestein","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.jep.2006.02.001_bib84","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0165-5728(03)00045-6","article-title":"Immunomodulatory effects of orally administered cannabinoids in multiple sclerosis","volume":"137","author":"Killestein","year":"2003","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.jep.2006.02.001_bib85","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/WNL.58.9.1404","article-title":"Safety, tolerability, and efficacy of orally administered cannabinoids in MS","volume":"58","author":"Killestein","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jep.2006.02.001_bib86","series-title":"Substance Abuse. A Comprehensive Textbook","first-page":"855","article-title":"Chapter 82: clinical and societal implications of drug legalization","author":"Kleber","year":"1997"},{"key":"10.1016\/j.jep.2006.02.001_bib87","first-page":"338","article-title":"Delta-9-tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancer chemotherapy: a double-blind cross-over trial against placebo","volume":"21","author":"Kluin-Neleman","year":"1979","journal-title":"Veterinarian and Human Toxicology"},{"key":"10.1016\/j.jep.2006.02.001_bib88","first-page":"203","article-title":"Cannabinoids and the immune system of men, mice and cells","volume":"18","author":"Kraft","year":"2004","journal-title":"Der Schmerz"},{"key":"10.1016\/j.jep.2006.02.001_bib89","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/02791072.1999.10471776","article-title":"Therapeutic use of cannabis by crack addicts in Brazil","volume":"31","author":"Labigalini","year":"1999","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.jep.2006.02.001_bib90","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0885-3924(91)90026-Z","article-title":"Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting","volume":"6","author":"Lane","year":"1991","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1016\/j.jep.2006.02.001_bib91","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0305-7372(82)80036-4","article-title":"Nabilone vs placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients","volume":"9","author":"Levitt","year":"1982","journal-title":"Cancer Treatment Reviews"},{"key":"10.1016\/j.jep.2006.02.001_bib92","first-page":"91","article-title":"Randomized double-blind comparison of delta-9-tetrahydrocannabinol (THC) and marijuana as chemotherapy antiemetics","volume":"3","author":"Levitt","year":"1984","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"key":"10.1016\/j.jep.2006.02.001_bib93","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF02862859","article-title":"An archaelogical and historical account of cannabis in China","volume":"28","author":"Li","year":"1974","journal-title":"Economic Botany"},{"key":"10.1016\/j.jep.2006.02.001_bib94","series-title":"Proceedings of the Marijuana 1987 International Conference on Cannabis","article-title":"Lack of effect of cannabidiol in sustained neuropathia","author":"Lindstrom","year":"1987"},{"key":"10.1016\/j.jep.2006.02.001_bib95","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0885-3924(03)00142-8","article-title":"Cannabis reduces opioid dose in the treatment of chronic non-cancer pain","volume":"25","author":"Lynch","year":"2003","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1016\/j.jep.2006.02.001_bib96","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(04)16200-4","article-title":"Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies","volume":"363","author":"Macleod","year":"2004","journal-title":"The Lancet"},{"key":"10.1016\/j.jep.2006.02.001_bib97","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.euroneuro.2003.08.001","article-title":"Participation of the opioid system in cannabinoid-induced anticiception and emotional-like responses","volume":"13","author":"Maldonado","year":"2003","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.jep.2006.02.001_bib98","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(95)90485-9","article-title":"Nabilone in the treatment of multiple sclerosis","volume":"345","author":"Martyn","year":"1995","journal-title":"The Lancet"},{"key":"10.1016\/j.jep.2006.02.001_bib99","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.jep.2006.02.001_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02190083","article-title":"Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial","volume":"240","author":"Maurer","year":"1990","journal-title":"European Archives of Psychiatry and Clinical Neurosciences"},{"key":"10.1016\/j.jep.2006.02.001_bib101","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00175407","article-title":"Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy","volume":"6","author":"McCabe","year":"1988","journal-title":"Investigational New Drugs"},{"key":"10.1016\/j.jep.2006.02.001_bib102","series-title":"Drugs and Behavior. An Introduction to Behavioral Pharmacology","author":"McKim","year":"2000"},{"key":"10.1016\/j.jep.2006.02.001_bib103","series-title":"Cannabinoids as Therapeutic Agents","first-page":"1","article-title":"Chapter 1: the pharmacohistory of Cannabis sativa","author":"Mechoulam","year":"1986"},{"key":"10.1016\/j.jep.2006.02.001_bib104","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0161-6420(80)35258-5","article-title":"Effect of marihuana on intraocular and blood pressure in glaucoma","volume":"87","author":"Merritt","year":"1980","journal-title":"Ophtalmology"},{"key":"10.1016\/j.jep.2006.02.001_bib105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.2042-7158.1981.tb13699.x","article-title":"Topical \u03949-tetrahydrocannabinol in hypertensive glaucomas","volume":"33","author":"Merritt","year":"1981","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.jep.2006.02.001_bib106","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0140-6736(04)16976-6","article-title":"Marijuana on the state","volume":"364","author":"Mirken","year":"2004","journal-title":"The Lancet"},{"key":"10.1016\/j.jep.2006.02.001_bib107","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2002-25028","article-title":"Treatment of Tourette's syndrome with \u03949-tetrahydrocannabinol (THC): a randomized crossover trial","volume":"35","author":"M\u00fcller-Vahl","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jep.2006.02.001_bib108","series-title":"Cannabis and Cannabinoids. Pharmacology, Toxicology and Therapeutic Potential","first-page":"205","article-title":"Chapter 18: Movement disorders","author":"M\u00fcller-Vahl","year":"2002"},{"key":"10.1016\/j.jep.2006.02.001_bib109","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4088\/JCP.v64n0417","article-title":"\u03949-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial","volume":"64","author":"M\u00fcller-Vahl","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jep.2006.02.001_bib110","first-page":"384","article-title":"Treatment of Tourette syndrome with delta-9-tetrahydrocannabinol (\u03949-THC): no influence on neuropsychological performance","volume":"28","author":"M\u00fcller-Vahl","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jep.2006.02.001_bib111","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1517\/14656566.4.10.1717","article-title":"Cannabinoids reduce symptoms of Tourette's syndrome","volume":"4","author":"M\u00fcller-Vahl","year":"2003","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.jep.2006.02.001_bib112","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jep.2006.02.001_bib113","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3959(03)00163-5","article-title":"The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC\u2013morphine combination in healthy subjects under experimental pain conditions","volume":"105","author":"Naef","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.jep.2006.02.001_bib114","doi-asserted-by":"crossref","first-page":"38S","DOI":"10.1002\/j.1552-4604.1981.tb02571.x","article-title":"Comparative trial of the antiemetic effects of THC and haloperidol","volume":"21","author":"Neidhart","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jep.2006.02.001_bib115","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/BF01728184","article-title":"Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy","volume":"64","author":"Niederle","year":"1986","journal-title":"Klinische Wochen-Schrift"},{"key":"10.1016\/j.jep.2006.02.001_bib116","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00000421-198508000-00013","article-title":"A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy","volume":"8","author":"Niiranen","year":"1985","journal-title":"American Journal of Clinical Oncology"},{"key":"10.1016\/j.jep.2006.02.001_bib117","doi-asserted-by":"crossref","unstructured":"Nolin, P.C., Kenny, C., Banks, T., Maheu, S., Rossiter, E., 2002. Cannabis: our position for a Canadian Public Policy. Report of the Senate Special Committee on Illegal Drugs. Senate of Canada, Ottawa, 706 p.","DOI":"10.3138\/9781442672680"},{"key":"10.1016\/j.jep.2006.02.001_bib118","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2044.2004.03674.x","article-title":"Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 \u2018N of 1\u2019 studies","volume":"59","author":"Notcutt","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jep.2006.02.001_bib119","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/cpt197518184","article-title":"The analgesic properties of delta-9-tetrahydrocannabinol and codeine","volume":"18","author":"Noyes","year":"1975","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.jep.2006.02.001_bib120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/j.1552-4604.1975.tb02348.x","article-title":"Analgesic effect of delta-9-tetrahydrocannabinol","volume":"15","author":"Noyes","year":"1975","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jep.2006.02.001_bib121","series-title":"On the Office of Medicinal Cannabis and its Products","author":"Office of Medicinal Cannabis","year":"2005"},{"key":"10.1016\/j.jep.2006.02.001_bib122","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1001\/archinte.140.11.1431","article-title":"Antiemetic effect of tetrahydrocannabinol compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis","volume":"140","author":"Orr","year":"1980","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.jep.2006.02.001_bib123","first-page":"421","article-title":"On the preparations of the Indian hemp, or gunjah (Cannabis indica): their effets on the animal system in health, and their utility in the treatment of tetanus and other convulsive diseases","author":"O'Shaugnessy","year":"1838","journal-title":"Transactions of Medical and Physical Society of Bengal"},{"key":"10.1016\/j.jep.2006.02.001_bib124","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1001\/jama.289.15.1929-b","article-title":"Modulation of the immune system in cannabis users","volume":"289","author":"Pacifici","year":"2003","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jep.2006.02.001_bib125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jbspin.2003.10.006","article-title":"Cannabis: the analgesic and antiinflammatory medication of the future?","volume":"71","author":"Perrot","year":"2004","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jep.2006.02.001_bib126","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0163-7258(02)00255-3","article-title":"Cannabinoids and multiple sclerosis","volume":"95","author":"Pertwee","year":"2002","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.jep.2006.02.001_bib127","series-title":"Cannabis in Medical Practice. A Legal, Historical, and Pharmacological Overview of the Therapeutic Use of Marijuana","first-page":"112","article-title":"Chapter 9: spasticity and chronic pain","author":"Petro","year":"1997"},{"key":"10.1016\/j.jep.2006.02.001_bib128","doi-asserted-by":"crossref","first-page":"413S","DOI":"10.1002\/j.1552-4604.1981.tb02621.x","article-title":"Treatment of human spasticity with \u0394-9-tetrahydrocannabinol","volume":"21","author":"Petro","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jep.2006.02.001_bib129","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1046\/j.1440-1614.2002.01089.x","article-title":"Cannabis use is not associated with the development of psychosis in an \u2018ultra\u2019 high-risk group","volume":"36","author":"Phillips","year":"2002","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1016\/j.jep.2006.02.001_bib130","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/nm1001-1099","article-title":"Cannabinoid activity curtails cocaine craving","volume":"7","author":"Piomelli","year":"2001","journal-title":"Nature Medicine"},{"key":"10.1016\/j.jep.2006.02.001_bib131","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00256701","article-title":"Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis","volume":"17","author":"Pomeroy","year":"1986","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"10.1016\/j.jep.2006.02.001_bib132","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.tins.2005.03.006","article-title":"Emerging properties of cannabinoid medicines in management of multiple sclerosis","volume":"28","author":"Pryce","year":"2005","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.jep.2006.02.001_bib133","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/cpt197721126","article-title":"Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlates of the analgesic response","volume":"21","author":"Raft","year":"1977","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.jep.2006.02.001_bib134","series-title":"The Pharmacology of Marihuana","first-page":"763","article-title":"\u03949-tetrahydrocannabinol as an effective antidepressant and appetite-stimulating agent in advanced cancer patients","author":"Regelson","year":"1976"},{"key":"10.1016\/j.jep.2006.02.001_bib135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1192\/bjp.178.2.107","article-title":"Therapeutic aspects of cannabis and cannabinoids","volume":"178","author":"Robson","year":"2001","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jep.2006.02.001_bib136","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000176753.45410.8b","article-title":"Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis","volume":"65","author":"Rog","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jep.2006.02.001_bib137","first-page":"748","article-title":"Uso m\u00e9dico de la marihuana y canabinoides sint\u00e9ticos","volume":"63","author":"Roncoroni","year":"2003","journal-title":"Medicina"},{"key":"10.1016\/j.jep.2006.02.001_bib138","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0009-3084(02)00159-7","article-title":"Effects of delta-9-tetrahydrocannabinol on human immune function and host defense","volume":"121","author":"Roth","year":"2002","journal-title":"Chemistry and Physics of Lipids"},{"key":"10.1016\/j.jep.2006.02.001_bib139","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJM198001173020302","article-title":"Antiemetics in patients receiving chemotherapy for cancer. A randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine","volume":"302","author":"Sallan","year":"1980","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jep.2006.02.001_bib140","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJM197510162931603","article-title":"Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy","volume":"293","author":"Sallan","year":"1975","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jep.2006.02.001_bib141","series-title":"Cannabinoids as Therapeutic Agents","first-page":"105","article-title":"Cannabinoids and analgesia","author":"Segal","year":"1986"},{"key":"10.1016\/j.jep.2006.02.001_bib142","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1212\/WNL.57.11.2108","article-title":"Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study","volume":"57","author":"Sieradzan","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jep.2006.02.001_bib143","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/02791072.1998.10399682","article-title":"Review of the American Medical Association Council on Scientific Affairs Report on Medical Marijuana","volume":"30","author":"Smith","year":"1998","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.jep.2006.02.001_bib144","first-page":"727","article-title":"Medicinal cannabis extracts for the treatment of multiple sclerosis","volume":"5","author":"Smith","year":"2004","journal-title":"Current Opinion in Investigational Drugs"},{"key":"10.1016\/j.jep.2006.02.001_bib145","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0091-3057(01)00533-0","article-title":"Antiemetic efficacy of smoked marijuana. Subjective and behavioral effects on nausea induced by syrup of ipecac","volume":"69","author":"S\u00f6derpalm","year":"2001","journal-title":"Pharmacology, Biochemistry and Behavior"},{"key":"10.1016\/j.jep.2006.02.001_bib146","series-title":"The Marihuana Papers","author":"Solomon","year":"1968"},{"key":"10.1016\/j.jep.2006.02.001_bib147","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/cpt1978234397","article-title":"Effect of a nitrogen analog of tetrahydrocannabinol on cancer pain","volume":"23","author":"Staquet","year":"1978","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.jep.2006.02.001_bib148","first-page":"219","article-title":"Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis","volume":"64","author":"Steele","year":"1980","journal-title":"Cancer Treatment Reports"},{"key":"10.1016\/j.jep.2006.02.001_bib149","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1177\/106002809302700701","article-title":"Effect of dronabinol on nutritional status in HIV infection","volume":"27","author":"Struwe","year":"1993","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1016\/j.jep.2006.02.001_bib150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.38149.566979.AE","article-title":"Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial","volume":"329","author":"Svendsen","year":"2004","journal-title":"British Medical Journal"},{"key":"10.1016\/j.jep.2006.02.001_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.323.7303.16","article-title":"Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review","volume":"323","author":"Tramer","year":"2001","journal-title":"British Medical Journal"},{"key":"10.1016\/j.jep.2006.02.001_bib152","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1300\/J251v07n01_04","article-title":"Delta-9-THC in the treatment of spasticity associated with multiple sclerosis","volume":"7","author":"Ungerleider","year":"1987","journal-title":"Advances in Alcohol and Substance Abuse"},{"key":"10.1016\/j.jep.2006.02.001_bib153","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/1097-0142(19820815)50:4<636::AID-CNCR2820500404>3.0.CO;2-4","article-title":"Cannabis and cancer chemotherapy. A comparison of oral delta-9-THC and prochlorperazine","volume":"50","author":"Ungerleider","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.jep.2006.02.001_bib154","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1191\/1352458504ms1048oa","article-title":"Efficacy, safety and tolerability of an oral administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study","volume":"10","author":"Vaney","year":"2004","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/j.jep.2006.02.001_bib155","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF02737700","article-title":"Marihuana: respiratory tract effects","volume":"15","author":"van Hoozen","year":"1997","journal-title":"Clinical Review of Allergy and Immunology"},{"key":"10.1016\/j.jep.2006.02.001_bib156","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/aje\/kwf043","article-title":"Cannabis use and psychosis: a longitudinal population-based study","volume":"156","author":"van Os","year":"2002","journal-title":"American Journal of Epidemology"},{"key":"10.1016\/j.jep.2006.02.001_bib157","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0305-7372(82)80034-0","article-title":"Double-blind, randomized, crossover trial of nabilone vs placebo in cancer chemotherapy","volume":"9","author":"Wada","year":"1982","journal-title":"Cancer Treatment Reviews"},{"key":"10.1016\/j.jep.2006.02.001_bib158","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","article-title":"Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients","volume":"10","author":"Wade","year":"2004","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/j.jep.2006.02.001_bib159","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1191\/0269215503cr581oa","article-title":"A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms","volume":"17","author":"Wade","year":"2003","journal-title":"Clinical Rehabilitation"},{"key":"10.1016\/j.jep.2006.02.001_bib160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00520-002-0387-7","article-title":"Established and potential therapeutic applications of cannabinoids in oncology","volume":"11","author":"Walsh","year":"2003","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jep.2006.02.001_bib161","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0140-6736(04)16741-X","article-title":"Cannabis for medical purposes: cultivating science, weeding out the fiction","volume":"364","author":"Wingerchuk","year":"2004","journal-title":"The Lancet"},{"key":"10.1016\/j.jep.2006.02.001_bib162","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1254\/jphs.FMJ04003X5","article-title":"New perspectives in the studies on endocannabinoid and cannabis: a role for the endocannabinoid\u2013arachidonic acid pathway in drug reward and long-lasting relapse to drug taking","volume":"96","author":"Yamamoto","year":"2004","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/j.jep.2006.02.001_bib163","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(03)14738-1","article-title":"Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicenter randomised placebo-controlled trial","volume":"362","author":"Zajicek","year":"2003","journal-title":"The Lancet"},{"key":"10.1016\/j.jep.2006.02.001_bib164","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1136\/jnnp.2005.070136","article-title":"Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up","volume":"76","author":"Zajicek","year":"2005","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1016\/j.jep.2006.02.001_bib165","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/bmj.325.7374.1199","article-title":"Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969; historical cohort study","volume":"325","author":"Zammit","year":"1969","journal-title":"British Medical Journal"},{"key":"10.1016\/j.jep.2006.02.001_bib166","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4049\/jimmunol.165.1.373","article-title":"D9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependant pathway","volume":"165","author":"Zhu","year":"2000","journal-title":"Journal of Immunology"}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874106000821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874106000821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T19:54:09Z","timestamp":1683402849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874106000821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":166,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0378874106000821"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2006.02.001","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}